Medline Europe in the news

Medline Industries LP's global employee count is projected to reach approximately 43,610 by March 2026, representing a 7.6% growth since 2023.

Medline is expanding its international operations by adapting its U.S. service models to local markets and healthcare systems through a 'glocal' approach.

Medline's international growth strategy focuses on a "glocal" approach, adapting products and services to local market needs rather than simply exporting U.S. models.

Expansion of the Partizánske manufacturing plant in Slovakia to boost medical device production capacity and supply chain reliability across Europe.

Medline International B.V. is expanding its manufacturing facility in Slovakia to increase capacity, strengthen supply chain resilience, and support long-term growth in Europe.

Medline is expanding its manufacturing capacity in Slovakia with a new facility to boost production and supply chain resilience in the EMEA region.

Medline is expanding its Slovakian manufacturing footprint with a new sustainable facility to boost medical device production and supply chain resilience across EMEA.

Medline is expanding its Slovakian manufacturing facility to increase medical-surgical product capacity and improve supply chain reliability across Europe.

A new manufacturing facility in Partizánske, Slovakia, is being constructed to increase medical-surgical product capacity and supply chain resilience across Europe.

A new medical device manufacturing facility is being built in Slovakia to increase production capacity and supply reliability for European healthcare providers by 2027.

A new manufacturing facility is being built in Slovakia to expand production capacity for medical-surgical products across Europe by 2027.

Medline is doubling its manufacturing footprint in Slovakia with a new facility scheduled to open in 2027 to serve the EMEA region.

Medline is building a new manufacturing facility in Slovakia to increase medical-grade plastic production and shorten its European supply chain by 2027.

Medline is building a new manufacturing facility in Slovakia to increase medical-surgical product capacity and supply chain resilience across Europe.

Medline Industries is facing an urgent FDA recall and potential regulatory action over faulty angiographic syringes that risk patient safety.

Medline launched an automated fulfillment system in its Montgomery distribution center to speed up direct-to-home deliveries for health plan members.

PE Hub honored Blackstone, Carlyle, and Hellman & Friedman with the Deal of the Year Award for their role in the Medline IPO.

Medline shares surged over 20% in their Nasdaq debut, valuing the medical supply company at $46.03 billion.

Medline's IPO successfully generated a 41% surge in share price, valuing the company at $55 billion and delivering more than double the initial investment for its private equity backers.

Medline faces international industrial action and legal challenges following its decision to shut down its Malta facility without offering worker compensation.